Skip to content
Off-topic for aiqbench

Off-topic for aiqbench

This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.

argenx's FB102 meets Phase 2 goal in coeliac disease

Dealroom.co1 min read

argenx's FB102 meets Phase 2 goal in coeliac disease  Dealroom

Read the full article at Dealroom.co

Related coverage